Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IMTX stock hub

Immatics N.V. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IMTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

IMTX

In the news

Latest news · IMTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-37.1

P25 -105.6P50 -46.5P75 -3.1

ROIC-1,116

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IMTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

195

Groups with data

Currency

EUR

Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001809196
Company name	Immatics N.V.
Country	Germany
Country code	US
Cusip	N44445109
Employees	711
Employees Change	29%
Employees Change Percent	4.25
Enterprise value	$992M
Exchange	NASDAQ
Financial currency	EUR
First seen	2026-05-09
Industry	Biotechnology
Isin	NL0015285941
Last refreshed	2026-05-10
Market cap	$1.5B
Market cap category	Small-Cap
Price	$11.37
Price currency	USD
Rev Per Employee	79,704.91x
Sector	Healthcare
Sic	2836
Symbol	IMTX
Website	https://www.immatics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-15.13%
EV Sales Forward	21.58x
EV/Sales	17.5x
FCF yield	-14.17%
P/B ratio	2.68x
P/S ratio	26.9x
PS Forward	33.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-280.87%
Gross Profit	$-159.2M
Net Income	$-230.7M
Net Income Growth Years	0%
Pretax Margin	-411.13%
Profit Per Employee	$-324,406
ROA	-18.08
Roa5y	-10.93
ROCE	-35.05
ROE	-37.1
Roe5y	-44.27
ROIC	-1,116

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	159.17%
Cagr3y	4.03%
Cagr5y	-0.26%
EPS Growth Years	0
Revenue Growth	-69.03x
Revenue Growth Q	-64.87x
Revenue Growth Years	0x
Revenue Growth3 Y	-34.64x
Revenue Growth5 Y	9.08x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.08
Assets	$660.3M
Cash	$551.1M
Current Assets	$594.4M
Current Liabilities	$50.7M
Debt	$18.4M
Debt Equity	$0.03
Equity	$568.4M
Interest Coverage	-192.4
Liabilities	$91.9M
Long Term Assets	$65.9M
Long Term Liabilities	$41.1M
Net Cash	$532.7M
Net Cash By Market Cap	$34.94
Net Cash Growth	-22.87%
Net Debt Equity	$-0.94
Tangible Book Value	$566.5M
Tangible Book Value Per Share	$4.23
WACC	11.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.72
Net Working Capital	$-6.6M
Quick ratio	11.07
Working Capital	$541.3M
Working Capital Turnover	$0.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.56%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	159%
200-day SMA	9.19
3Y total return	12.57%
50-day SMA	10.41
50-day SMA vs 200-day SMA	50over200
5Y total return	-1.3%
All Time High	18.42
All Time High Change	-38.27%
All Time High Date	2021-03-17
All Time Low	3.3
All Time Low Change	244.55%
All Time Low Date	2025-04-07
ATR	0.52
Beta	1.31
Beta1y	0.81
Beta2y	1.33
Ch YTD	8.29
High	11.49
High52	12.41
High52 Date	2025-12-04
High52ch	-8.38%
Low	11.08
Low52	4.06
Low52 Date	2025-05-08
Low52ch	180.05%
Ma50ch	9.25%
Price vs 200-day SMA	23.67%
RSI	57.35
RSI Monthly	59
RSI Weekly	62.85
Sharpe ratio	1.73x
Sortino ratio	3.03
Total Return	-14.56%
Tr YTD	8.29
Tr1m	10.93%
Tr1w	5.38%
Tr3m	18.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	2
Analyst Price Target Top	$24
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.42
Earnings Revenue Estimate	14,590,000x
Earnings Revenue Estimate Growth	-25.34x
Operating Income	$-213.7M
Operating margin	-377.1
Price target	$19
Price Target Change	$67.11
Price Target Change Top	$111

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	67,268,425%
Float Percent	50.16%
Net Borrowing	-3,489,543.2
Shares Insiders	3.51%
Shares Institutions	45.93%
Shares Out	134,096,576
Shares Qo Q	2.6%
Shares Yo Y	14.56%
Short Float	7.62%
Short Ratio	13.16
Short Shares	3.82

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-233.7M
Average Volume	367,324.7x
Bv Per Share	4.24
CAPEX	$-7.7M
Ch1m	10.93
Ch1w	5.38
Ch1y	159
Ch3m	18.07
Ch3y	12.57
Ch5y	-1.3
Ch6m	25.64
Change	2.06%
Change From Open	2.16
Close	11.14
Days Gap	-0.09
Depreciation Amortization	10,779,964.2
Dollar Volume	4,275,927.3
Earnings Date	2026-05-13
Earnings Time	bmo
EBIT	$-213.7M
EBITDA	$-203M
EPS	$-1.89
F Score	2
FCF	$-216M
FCF EV Yield	-21.78x
FCF Per Share	$-1.61
Financing CF	114,304,333
Fiscal Year End	December
Income Tax	$-2.3M
Investing CF	240,444,992
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-05
Ma150	10.14
Ma150ch	12.1%
Ma20	11.15
Ma20ch	1.94%
Net CF	128,178,936
Next Earnings Date	2026-05-22
Open	11.13
Optionable	Yes
Position In Range	70.73
Ppne	64,739,929.4
Price Date	2026-05-08
Ptbv Ratio	2.69
Relative Volume	1.02x
Revenue	56,670,189x
SBC By Revenue	31.11x
Share Based Comp	17,629,447
Tax By Revenue	-4.12x
Tr6m	25.64%
Volume	376,071
Z Score	3.53

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IMTX pay a dividend?

Capital-return profile for this ticker.

Performance

IMTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IMTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+45.9%

Float: +50.2% of shares outstanding

Insider ownership

+3.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IMTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.3

Neutral momentum band

Price vs 200-day MA

+23.7%

50/200-day relationship not available

Beta (5Y)

1.31

More volatile than the market

Sharpe ratio

1.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IMTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IMTX stock rating?

Immatics N.V. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IMTX analysis?

The full report lives at /stocks/IMTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IMTX?

The latest report frames IMTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IMTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.